WNTinib is a multi-kinase inhibitor with specificity against β-catenin mutant hepatocellular carcinoma von Rialdi, Alex, Duffy, Mary, Scopton, Alex P, Fonseca, Frank, Zhao, Julia Nanyi, Schwarz, Megan, Molina-Sanchez, Pedro, Mzoughi, Slim, Arceci, Elisa, Abril-Fornaguera, Jordi, Meadows, Austin, Ruiz de Galarreta, Marina, Torre, Denis, Reyes, Kyna, Lim, Yan Ting, Rosemann, Felix, Khan, Zaigham M, Mohammed, Kevin, Wang, Xuedi, Yu, Xufen, Lakshmanan, Manikandan, Rajarethinam, Ravisankar, Tan, Soo Yong, Jin, Jian, Villanueva, Augusto, Michailidis, Eleftherios, De Jong, Ype P, Rice, Charles M, Marazzi, Ivan, Hasson, Dan, Llovet, Josep M, Sobota, Radoslaw M, Lujambio, Amaia, Guccione, Ernesto, Dar, Arvin C

Volltext